This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
12 - 14 Nov 2024
Hamburg Congress CentreHamburg, Germany

Lihu Yang, PhD
Head of Discovery Chemistry US at UCB
Speaker

Profile

Dr. Lihu Yang is currently the head of Discovery Chemistry US (with the focus on peptide therapeutics) of UCB in Cambridge USA. He joined UCB in 2017 as head of External Innovations in Asia. Before that, Lihu spent more than twenty-six years at Merck & Co. (known as MSD outside of the US) as a medicinal chemist working in the areas of immunology, endocrine and infectious diseases (TB). Dr. Yang received his PhD from Rice University (Houston, TX, USA) and a BS from Nankai University (Tianjin, China)

Agenda Sessions

  • Discovery of Zilucoplan: A Potent Macrocyclic Peptide Complement Component 5 (C5) Inhibitor in Acetylcholine Receptor Antibody-positive Generalized Myasthenia Gravis

    14:30